TransUnion LLC v. Ramirez

|

(U.S., filed February 8, 2021): Urging the Court to review whether a lead plaintiff who is injured satisfies the Rule 23 typicality requirement for those who are not. The Court should define the scope of a rigorous analysis for typicality under Rule 23 (A)(3). Ensuring typicality of injury would help avoid problems caused by uninjured class members.  

View Amicus Brief

Case not yet decided

Latest News

View all news

SCOTUS Should Affirm Federal Law Supremacy With FDA Authority Case

The U.S. Supreme Court has a chance to rein in state court rulings that impose liability on pharmaceutical companies that go beyond, and even contradict, the federal regulatory process of the FDA, according to Tiger Joyce, president of the American Tort Reform Association. He explains why it is imperative the high court review a case involving Janssen Pharmaceuticals.